Mangalam Drugs And Organics Limited has informed the Exchange regarding Outcome of Board Meeting held on March 26, 2026.
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mangalam Drugs and Organics held a board meeting on March 26, 2026 (12:00 PM to 12:40 PM). The board accepted the resignation of Ms. Anuradha Pandey from the position of Company Secretary & Compliance Officer, with her last working day being March 29, 2026. She is stepping down to pursue opportunities outside the company. To fill the vacancy, the board approved the appointment of Ms. Shweta Patel as the new Company Secretary & Compliance Officer, effective April 1, 2026. Ms. Patel is an Associate Member of the ICSI with about 3 years of experience in corporate compliance for listed and unlisted companies. Apart from this change, only routine matters were discussed. The company is a WHO-GMP certified pharmaceutical manufacturer based in Mumbai with a factory in Vapi, Gujarat.
This is a routine key managerial personnel change with no direct financial or strategic impact on the business. Shareholders are unlikely to see any meaningful effect on the stock price, as Company Secretary transitions are standard governance matters and a replacement has already been lined up with a brief handover overlap.